Study of ASN003 in Subjects With Advanced Solid Tumors
A Phase 1, Open-label, Dose-finding and Cohort Expansion Study of ASN003 in Subjects With Advanced Solid Tumors
Sponsor: Asana BioSciences
Terminated
reformulation
Other terminated trials from Asana BioSciences
Other Carcinoma, Non-small Cell Lung trials with similar outcome
A PHASE1 clinical study on Carcinoma, Non-small Cell Lung and Colorectal Neoplasm, this trial is terminated or withdrawn. The trial is conducted by Asana BioSciences and has accumulated 13 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Jun 2023 — Jul 2024 [monthly]
Terminated PHASE1
-
Mar 2023 — Jun 2023 [monthly]
Terminated PHASE1
-
Feb 2023 — Mar 2023 [monthly]
Terminated PHASE1
▶ Show 8 earlier versions
-
Jan 2021 — Feb 2023 [monthly]
Terminated PHASE1
-
Jun 2019 — Jan 2021 [monthly]
Terminated PHASE1
Status: Active Not Recruiting → Terminated
-
Jun 2018 — Jun 2019 [monthly]
Active Not Recruiting PHASE1
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Feb 2018 — May 2018 [monthly]
Recruiting PHASE1
-
Jul 2017 — Feb 2018 [monthly]
Recruiting PHASE1
-
Feb 2017 — Jul 2017 [monthly]
Recruiting PHASE1
Phase: PHASE1_PHASE2 → PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Oct 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Asana BioSciences
For direct contact, visit the study record on ClinicalTrials.gov .